SEC Form 4 research
| Issuer | Arcutis Biotherapeutics, Inc. |
|---|---|
| Tickers | ARQT |
| Reporting owners | 42 |
| Officers and directors | 20 |
| Last public filing | 2026-11-04 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-04 | 2026-11-04 | Matsuda Masaru | S | 40,000 | $34.32 | Not reported |
| 2026-11-04 | 2026-11-02 | Matsuda Masaru | S | 1,219 | $31.86 | Not reported |
| 2026-11-04 | 2026-11-02 | Burnett Patrick | S | 943 | $31.86 | Not reported |
| 2026-11-04 | 2026-11-02 | Watanabe Todd | S | 4,377 | $31.86 | Not reported |
| 2026-10-28 | 2026-10-23 | SCOTT ROBERT A | A | 8,663 | $0 | Not reported |
| 2026-10-28 | 2026-10-23 | SCOTT ROBERT A | A | 2,819 | $0 | Not reported |
| 2026-10-28 | 2026-10-23 | SCOTT ROBERT A | A | 20,507 | $0 | Not reported |
| 2026-10-19 | 2026-10-15 | Welgus Howard G. | S | 4,728 | $26.93 | Not reported |
| 2026-09-18 | 2026-09-16 | Matsuda Masaru | S | 3,674 | $25 | Not reported |
| 2026-09-17 | 2026-09-15 | Welgus Howard G. | S | 4,730 | $24.18 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.